These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 7867381)

  • 1. Chilblain lupus erythematosus (lupus pernio): clinical review of the Mayo Clinic experience and proposal of diagnostic criteria.
    Su WP; Perniciaro C; Rogers RS; White JW
    Cutis; 1994 Dec; 54(6):395-9. PubMed ID: 7867381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chilblain lupus erythematosus associated with systemic and discoid lupus erythematosus.
    Cardenas-de la Garza JA; Arvizu-Rivera RI; Ocampo-Candiani J; Galarza-Delgado DA
    Rheumatology (Oxford); 2021 Feb; 60(2):988. PubMed ID: 32856084
    [No Abstract]   [Full Text] [Related]  

  • 3. Chilblain lupus erythematosus.
    Patel S; Hardo F
    BMJ Case Rep; 2013 Nov; 2013():. PubMed ID: 24285807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chilblain lupus erythematosus lesions precipitated by the cold.
    Helm TN; Jones CM
    Cutis; 2002 Mar; 69(3):183-4, 190. PubMed ID: 11926337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chilblain lupus in an adolescent].
    Brănişteanu DE; Molodoi AD; Stătescu L; Petrescu Z; Vasiluţ D; Anisiei E; Ferariu D; Brănişteanu D
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(3):646-51. PubMed ID: 20201246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chilblain lupus erythematosus].
    Uter W; Proksch E; Schauder S
    Hautarzt; 1988 Sep; 39(9):602-5. PubMed ID: 3182275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chilblain lupus erythematosus. A case report].
    Brado B; Keilholz U; Tilgen W; Pezzutto A; Gissler M; Hunstein W
    Internist (Berl); 1992 Oct; 33(10):701-3. PubMed ID: 1428687
    [No Abstract]   [Full Text] [Related]  

  • 8. Chilblains in immune-mediated inflammatory diseases: a review.
    Dubey S; Joshi N; Stevenson O; Gordon C; Reynolds JA
    Rheumatology (Oxford); 2022 Nov; 61(12):4631-4642. PubMed ID: 35412601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous manifestations of systemic lupus erythematosus.
    Yell JA; Mbuagbaw J; Burge SM
    Br J Dermatol; 1996 Sep; 135(3):355-62. PubMed ID: 8949425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Classification of dermatologic manifestations in lupus erythematosus].
    Francès C; Barete S; Ayoub N; Piette JC
    Ann Med Interne (Paris); 2003 Feb; 154(1):33-44. PubMed ID: 12746657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics, etiologic associations, laboratory findings, treatment, and proposal of diagnostic criteria of pernio (chilblains) in a series of 104 patients at Mayo Clinic, 2000 to 2011.
    Cappel JA; Wetter DA
    Mayo Clin Proc; 2014 Feb; 89(2):207-15. PubMed ID: 24485134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous lupus erythematosus: issues in diagnosis and treatment.
    Walling HW; Sontheimer RD
    Am J Clin Dermatol; 2009; 10(6):365-81. PubMed ID: 19824738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Clinical Response to Janus Kinase Inhibition in Patients With Familial Chilblain Lupus and TREX1 Mutation.
    Zimmermann N; Wolf C; Schwenke R; Lüth A; Schmidt F; Engel K; Lee-Kirsch MA; Günther C
    JAMA Dermatol; 2019 Mar; 155(3):342-346. PubMed ID: 30673078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lupus pernio or chilblain lupus?: two different entities.
    Arias-Santiago SA; Girón-Prieto MS; Callejas-Rubio JL; Fernández-Pugnaire MA; Ortego-Centeno N
    Chest; 2009 Sep; 136(3):946-947. PubMed ID: 19736207
    [No Abstract]   [Full Text] [Related]  

  • 15. Chilblain lupus erythematosus (Hutchinson). A clinical and laboratory study of 17 patients.
    Millard LG; Rowell NR
    Br J Dermatol; 1978 May; 98(5):497-506. PubMed ID: 656324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of male who was taken systemic lupus erythematosus with chilblain lupus].
    Takeda S; Tatara I; Kono K
    Ryumachi; 1998 Jun; 38(3):529-33. PubMed ID: 9721562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel-induced relapse of subacute cutaneous lupus erythematosus and chilblain lupus.
    Lebeau S; També S; Sallam MA; Alhowaish A; Tschanz C; Masouyé I; Borradori L
    J Dtsch Dermatol Ges; 2013 Sep; 11(9):871-4. PubMed ID: 23848065
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of the past history of chilblain in cases of systemic lupus erythematosus (SLE) and its similar diseases].
    Morioka N; Tsuchida T; Ueda Y; Ishibashi Y
    Nihon Hifuka Gakkai Zasshi; 1991 May; 101(6):615-22. PubMed ID: 1920892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chilblain lupus erythematosus: report of 15 cases.
    Doutre MS; Beylot C; Beylot J; Pompougnac E; Royer P
    Dermatology; 1992; 184(1):26-8. PubMed ID: 1558991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Subacute cutaneous lupus erythematosus based on a study of 15 cases].
    Marschalkó M; Dobozy E; Daróczy J; Gyimesi E; Horváth A
    Orv Hetil; 1989 Dec; 130(49):2623-8. PubMed ID: 2689950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.